Table 1.

Characteristics of the subjects’ groups.

Clinical Parameters (normal range)	CLL Patients	Normal Controls
n	30	12
Gender (male/female)	14/16	5/7
Age (years)	69.4 ± 10.9	59.7 ± 10.1
Serum C3 mg/dl (82–158)	109.7 ± 23.9	125.4 ± 21.5
Serum C4 mg/dl (15–35)	28.2 ± 8.8	29.3 ± 2.3
Cholesterol mg/dl (<200)	158.1 ± 35.2	203.6 ± 80.9
Triglycerides mg/dl (<150)	144.3 ± 78.5	177.1 ± 72.9
HDL mg/dl (>40)	37.8 ± 13.6	43.7 ± 9.6
LDL mg/dl (<100)	91.3 ± 38.7	112 ± 52.4
Non-HDL chol. mg/dl (<130)	120.1 ± 31.2	160.1 ± 80.5
Platlet X10e3/µl (130–400)	164.17 ± 75.9*	272.5 ± 98.3
WBC X10e3/µl (4–10)	33.3 ± 69.3*	7.4 ± 2.8
HGB g/dl (13–18)	13 ± 2.01	13.6 ± 1.1
Neutro abs X10e3/µl (1.5–8)	4.6 ± 2.1	4.7 ± 2.4

All values are given as mean ± SEM.

*indicates significant p value (p < 0.05).